BIOMAT Database Logo BIOMAT Database Logo

Prevalence of HBV HDV and LAV/HTLV-III infections among Greek drug addicts. 1987

A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou

UI MeSH Term Description Entries
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D003699 Hepatitis D INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Amazon Black Fever,Black Fever, Amazon,Delta Hepatitis,Delta Infection,Delta Superinfection,Hepatitis, Delta,Labrea Disease,Infection, Delta,Superinfection, Delta,Delta Superinfections,Disease, Labrea,Diseases, Labrea,Fever, Amazon Black,Hepatitides, Delta,Infections, Delta,Labrea Diseases,Superinfections, Delta
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
[HBV, HDV and HTLV-III infections in drug addicts, cirrhotics and hemodialysis patients].
October 1986, Bollettino della Societa italiana di biologia sperimentale,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
Prevalence of anti-LAV/HTLV-III in Portuguese drug addicts and hemodialyzed patients.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
[Viral hepatitis and AIDS-associated HTLV III/LAV virus infections in drug addicts].
August 1985, Schweizerische medizinische Wochenschrift,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
Isolation of HTLV III/LAV from drug addicts in Palermo.
January 1987, Microbiologica,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
HCV, HIV, HBV and HDV infections in intravenous drug addicts.
June 1994, European journal of epidemiology,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
January 1987, Bollettino dell'Istituto sieroterapico milanese,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
Prevalence of HTLV-III/LAV antibodies among Haitians.
June 1985, The New England journal of medicine,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
[Penetration of LAV/HTLV-III and infectious complications in parenteral drug addicts].
January 1986, Medicina clinica,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
[Prevalence and morbidity of HTLV-III/LAV infection in homosexuals and parenteral drug addicts (up-date 1985)].
January 1987, Medicina clinica,
A Roumeliotou-Karayannis, and N Tassopoulos, and M Kotsianopoulou, and E Karpodini, and E Trichopoulou, and G Papaevangelou
[Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
April 1986, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!